Using signaling pathways to overcome immune tolerance to tumors.
about
Murine melanoma-infiltrating dendritic cells are defective in antigen presenting function regardless of the presence of CD4CD25 regulatory T cellsPhotodynamic therapy induces interleukin secretion from dendritic cells.Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cellsDevelopment of an MHC class I L(d)-restricted PSA peptide-loaded tetramer for detection of PSA-specific CD8+ T cells in the mouse.
P2860
Using signaling pathways to overcome immune tolerance to tumors.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Using signaling pathways to overcome immune tolerance to tumors.
@ast
Using signaling pathways to overcome immune tolerance to tumors.
@en
type
label
Using signaling pathways to overcome immune tolerance to tumors.
@ast
Using signaling pathways to overcome immune tolerance to tumors.
@en
prefLabel
Using signaling pathways to overcome immune tolerance to tumors.
@ast
Using signaling pathways to overcome immune tolerance to tumors.
@en
P2093
P2860
P356
P1476
Using signaling pathways to overcome immune tolerance to tumors.
@en
P2093
Edgar G Engleman
Joshua Brody
Luis Soares
P2860
P356
10.1126/STKE.2412004PE28
P577
2004-07-06T00:00:00Z